385 related articles for article (PubMed ID: 34511911)
1. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
2. Versatile polymer-based strategies for antibacterial drug delivery systems and antibacterial coatings.
You K; Gao B; Wang M; Wang X; Okoro KC; Rakhimbekzoda A; Feng Y
J Mater Chem B; 2022 Feb; 10(7):1005-1018. PubMed ID: 35089304
[TBL] [Abstract][Full Text] [Related]
3. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
[TBL] [Abstract][Full Text] [Related]
4. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
[TBL] [Abstract][Full Text] [Related]
5. Research progress of nanoparticle targeting delivery systems in bacterial infections.
Jin M; He B; Cai X; Lei Z; Sun T
Colloids Surf B Biointerfaces; 2023 Sep; 229():113444. PubMed ID: 37453264
[TBL] [Abstract][Full Text] [Related]
6. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
[TBL] [Abstract][Full Text] [Related]
8. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterials with active targeting as advanced antimicrobials.
Smerkova K; Dolezelikova K; Bozdechova L; Heger Z; Zurek L; Adam V
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1636. PubMed ID: 32363802
[TBL] [Abstract][Full Text] [Related]
10. Expert opinion on antimicrobial therapies: is there enough scientific evidence to state that targeted therapies outperform non-targeted ones?
Yus C; Gámez E; Arruebo M
Expert Opin Drug Deliv; 2024 Apr; 21(4):593-609. PubMed ID: 38619078
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for combating biofilms: Advantages and challenges.
Zhang Y; Lin S; Fu J; Zhang W; Shu G; Lin J; Li H; Xu F; Tang H; Peng G; Zhao L; Chen S; Fu H
J Appl Microbiol; 2022 Sep; 133(3):1273-1287. PubMed ID: 35621701
[TBL] [Abstract][Full Text] [Related]
12. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
[TBL] [Abstract][Full Text] [Related]
13. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
Huh AJ; Kwon YJ
J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
16. Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review.
Yao L; Liu Q; Lei Z; Sun T
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126819. PubMed ID: 37709236
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane-coated nanoparticles for the treatment of bacterial infection.
Ma J; Jiang L; Liu G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1825. PubMed ID: 35725897
[TBL] [Abstract][Full Text] [Related]
18. Nanomaterials for alternative antibacterial therapy.
Hemeg HA
Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
[TBL] [Abstract][Full Text] [Related]
19. The current novel drug delivery system (natural and chemical composites) in dental infections for antibiotics resistance: a narrative review.
Tahmasebi E; Kaboudanian Ardestani A; Hassani Z; Alam M; Abbasi K; Kahrizi S; Madihi N; Abbasiparashkouh Z; Mohammadi A; Shahab P; Khayatan D; Yazdanian M
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):141-160. PubMed ID: 37114257
[TBL] [Abstract][Full Text] [Related]
20. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
Engin AB; Engin A
Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
